230 related articles for article (PubMed ID: 32236581)
21. Congenital generalized lipodystrophy in Taiwan.
Hsu RH; Lin WD; Chao MC; Hsiao HP; Wong SL; Chiu PC; Chu SY; Ke YY; Lau BH; Chien YH; Hwu WL; Tsai FJ; Wang CH; Lee NC
J Formos Med Assoc; 2019 Jan; 118(1 Pt 1):142-147. PubMed ID: 29478747
[TBL] [Abstract][Full Text] [Related]
22. Founder effect of the 669insA mutation in BSCL2 gene causing Berardinelli-Seip congenital lipodystrophy in a cluster from Brazil.
Gomes KB; Pardini VC; Ferreira AC; Fonseca CG; Fernandes AP
Ann Hum Genet; 2007 Nov; 71(Pt 6):729-34. PubMed ID: 17535271
[TBL] [Abstract][Full Text] [Related]
23. Impaired adipogenic capacity in induced pluripotent stem cells from lipodystrophic patients with BSCL2 mutations.
Mori E; Fujikura J; Noguchi M; Nakao K; Matsubara M; Sone M; Taura D; Kusakabe T; Ebihara K; Tanaka T; Hosoda K; Takahashi K; Asaka I; Inagaki N; Nakao K
Metabolism; 2016 Apr; 65(4):543-56. PubMed ID: 26975546
[TBL] [Abstract][Full Text] [Related]
24. Metreleptin Treatment in a Boy with Congenital Generalized Lipodystrophy due to Homozygous c.465_468delGACT (p.T156Rfs*8) Mutation in the
Özalkak Ş; Demiral M; Ünal E; Taş FF; Onay H; Demirbilek H; Özbek MN
J Clin Res Pediatr Endocrinol; 2023 Aug; 15(3):329-333. PubMed ID: 35735786
[TBL] [Abstract][Full Text] [Related]
25. Whole Exome Sequencing Reveals a BSCL2 Mutation Causing Progressive Encephalopathy with Lipodystrophy (PELD) in an Iranian Pediatric Patient.
Alaei MR; Talebi S; Ghofrani M; Taghizadeh M; Keramatipour M
Iran Biomed J; 2016 Nov; 20(5):295-301. PubMed ID: 27452399
[TBL] [Abstract][Full Text] [Related]
26. Novel subtype of congenital generalized lipodystrophy associated with muscular weakness and cervical spine instability.
Simha V; Agarwal AK; Aronin PA; Iannaccone ST; Garg A
Am J Med Genet A; 2008 Sep; 146A(18):2318-26. PubMed ID: 18698612
[TBL] [Abstract][Full Text] [Related]
27. Novel mutations of the BSCL2 and AGPAT2 genes in 10 families with Berardinelli-Seip congenital generalized lipodystrophy syndrome.
Miranda DM; Wajchenberg BL; Calsolari MR; Aguiar MJ; Silva JM; Ribeiro MG; Fonseca C; Amaral D; Boson WL; Resende BA; De Marco L
Clin Endocrinol (Oxf); 2009 Oct; 71(4):512-7. PubMed ID: 19226263
[TBL] [Abstract][Full Text] [Related]
28. Phenotypic and genetic heterogeneity in congenital generalized lipodystrophy.
Agarwal AK; Simha V; Oral EA; Moran SA; Gorden P; O'Rahilly S; Zaidi Z; Gurakan F; Arslanian SA; Klar A; Ricker A; White NH; Bindl L; Herbst K; Kennel K; Patel SB; Al-Gazali L; Garg A
J Clin Endocrinol Metab; 2003 Oct; 88(10):4840-7. PubMed ID: 14557463
[TBL] [Abstract][Full Text] [Related]
29. Severe cardiac phenotype of Berardinelli-Seip congenital lipodystrophy in an infant with homozygous E189X BSCL2 mutation.
Friguls B; Coroleu W; del Alcazar R; Hilbert P; Van Maldergem L; Pintos-Morell G
Eur J Med Genet; 2009; 52(1):14-6. PubMed ID: 19041432
[TBL] [Abstract][Full Text] [Related]
30. Type 2 Congenital Generalized Lipodystrophy: The Diagnosis is in Your Hands.
Montenegro RM; Fernandes VO; Penaforte Saboia JG; Montenegro APDR; Lima JG
J Pediatr; 2019 Apr; 207():257-257.e1. PubMed ID: 30579587
[No Abstract] [Full Text] [Related]
31. Identification of pathogenic mutations in 6 Chinese families with multiple exostoses by whole-exome sequencing and multiplex ligation-dependent probe amplification: Case series.
Long X; Li Z; Huang Y; Zhang L; Lv W; Teng Y; Linpeng S; Liang D; Wu L
Medicine (Baltimore); 2019 May; 98(20):e15692. PubMed ID: 31096510
[TBL] [Abstract][Full Text] [Related]
32. Targeting ATGL to rescue BSCL2 lipodystrophy and its associated cardiomyopathy.
Zhou H; Lei X; Yan Y; Lydic T; Li J; Weintraub NL; Su H; Chen W
JCI Insight; 2019 Jun; 5(14):. PubMed ID: 31185001
[TBL] [Abstract][Full Text] [Related]
33. Role of Seipin in Human Diseases and Experimental Animal Models.
Li Y; Yang X; Peng L; Xia Q; Zhang Y; Huang W; Liu T; Jia D
Biomolecules; 2022 Jun; 12(6):. PubMed ID: 35740965
[TBL] [Abstract][Full Text] [Related]
34. A new seipin-associated neurodegenerative syndrome.
Guillén-Navarro E; Sánchez-Iglesias S; Domingo-Jiménez R; Victoria B; Ruiz-Riquelme A; Rábano A; Loidi L; Beiras A; González-Méndez B; Ramos A; López-González V; Ballesta-Martínez MJ; Garrido-Pumar M; Aguiar P; Ruibal A; Requena JR; Araújo-Vilar D
J Med Genet; 2013 Jun; 50(6):401-9. PubMed ID: 23564749
[TBL] [Abstract][Full Text] [Related]
35. Biallelic mutations at PPARG cause a congenital, generalized lipodystrophy similar to the Berardinelli-Seip syndrome.
Dyment DA; Gibson WT; Huang L; Bassyouni H; Hegele RA; Innes AM
Eur J Med Genet; 2014 Sep; 57(9):524-6. PubMed ID: 24980513
[TBL] [Abstract][Full Text] [Related]
36. Heterozygous deletion of Seipin in islet beta cells of male mice has an impact on insulin synthesis and secretion through reduced PPARγ expression.
Xiong J; Sun P; Wang Y; Hua X; Song W; Wang Y; Wu J; Yu W; Liu G; Chen L
Diabetologia; 2020 Feb; 63(2):338-350. PubMed ID: 31776610
[TBL] [Abstract][Full Text] [Related]
37. [Unusual facies and recurrent high triglycerides for more than one year in a girl].
Yin ZX; He XL; Zou RY
Zhongguo Dang Dai Er Ke Za Zhi; 2018 Dec; 20(12):1050-1054. PubMed ID: 30572997
[TBL] [Abstract][Full Text] [Related]
38. Ablation of
Mcilroy GD; Mitchell SE; Han W; Delibegović M; Rochford JJ
Dis Model Mech; 2020 Jan; 13(1):. PubMed ID: 31848133
[TBL] [Abstract][Full Text] [Related]
39. Juvenile-onset generalized lipodystrophy due to a novel heterozygous missense LMNA mutation affecting lamin C.
Patni N; Xing C; Agarwal AK; Garg A
Am J Med Genet A; 2017 Sep; 173(9):2517-2521. PubMed ID: 28686329
[TBL] [Abstract][Full Text] [Related]
40. Genotype-phenotype correlations of Berardinelli-Seip congenital lipodystrophy and novel candidate genes prediction.
Ren M; Shi J; Jia J; Guo Y; Ni X; Shi T
Orphanet J Rare Dis; 2020 Apr; 15(1):108. PubMed ID: 32349771
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
